2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea

Committee of Clinical Practice Guidelines; Korean Diabetes Association

doi:10.4093/dmj.2019.0137

2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea

Committee of Clinical Practice Guidelines
, Korean Diabetes Association

Soonchunhyang University
Yonsei University
Inje University
CHA University
Gwangmyeong Sungae Hospital
Sungkyunkwan University
Kyung Hee University
Seoul National University Boramae Hospital
Korea University
Chosun University
Sejong St. Mary’s Diabetes and Endocrine Clinic
Kangbuk Samsung Hospital
Hanyang University
Ajou University
Seoul National University

Research output: Contribution to journal › Article › peer-review

182 Scopus citations

Abstract

The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.

Original language	English
Pages (from-to)	398-406
Number of pages	9
Journal	Diabetes and Metabolism Journal
Volume	43
Issue number	4
DOIs	https://doi.org/10.4093/dmj.2019.0137
State	Published - 1 Aug 2019

Bibliographical note

Publisher Copyright:
Copyright © 2019 Korean Diabetes Association.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Diabetes mellitus, type 2
Diagnosis
Practice guideline
Therapeutics

Access to Document

10.4093/dmj.2019.0137

Cite this

@article{7fcb05b972c9471d9909c0539129e2b5,

title = "2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea",

abstract = "The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.",

keywords = "Diabetes mellitus, type 2, Diagnosis, Practice guideline, Therapeutics",

author = "\{Committee of Clinical Practice Guidelines\} and \{Korean Diabetes Association\} and Kim, \{Mee Kyoung\} and Ko, \{Seung Hyun\} and Kim, \{Bo Yeon\} and Kang, \{Eun Seok\} and Junghyun Noh and Kim, \{Soo Kyung\} and Park, \{Seok O.\} and Hur, \{Kyu Yeon\} and Suk Chon and Moon, \{Min Kyong\} and Kim, \{Nan Hee\} and Kim, \{Sang Yong\} and Rhee, \{Sang Youl\} and Lee, \{Kang Woo\} and Kim, \{Jae Hyeon\} and Rhee, \{Eun Jung\} and Chun, \{Sung Wan\} and Yu, \{Sung Hoon\} and Kim, \{Dae Jung\} and Kwon, \{Hyuk Sang\} and Park, \{Kyong Soo\}",

note = "Publisher Copyright: Copyright {\textcopyright} 2019 Korean Diabetes Association.",

year = "2019",

month = aug,

day = "1",

doi = "10.4093/dmj.2019.0137",

language = "English",

volume = "43",

pages = "398--406",

journal = "Diabetes and Metabolism Journal",

issn = "2233-6079",

publisher = "Korean Diabetes Association",

number = "4",

}

TY - JOUR

T1 - 2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea

AU - Committee of Clinical Practice Guidelines

AU - Korean Diabetes Association

AU - Kim, Mee Kyoung

AU - Ko, Seung Hyun

AU - Kim, Bo Yeon

AU - Kang, Eun Seok

AU - Noh, Junghyun

AU - Kim, Soo Kyung

AU - Park, Seok O.

AU - Hur, Kyu Yeon

AU - Chon, Suk

AU - Moon, Min Kyong

AU - Kim, Nan Hee

AU - Kim, Sang Yong

AU - Rhee, Sang Youl

AU - Lee, Kang Woo

AU - Kim, Jae Hyeon

AU - Rhee, Eun Jung

AU - Chun, Sung Wan

AU - Yu, Sung Hoon

AU - Kim, Dae Jung

AU - Kwon, Hyuk Sang

AU - Park, Kyong Soo

PY - 2019/8/1

Y1 - 2019/8/1

N2 - The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.

AB - The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.

KW - Diabetes mellitus, type 2

KW - Diagnosis

KW - Practice guideline

KW - Therapeutics

UR - https://www.scopus.com/pages/publications/85072118225

U2 - 10.4093/dmj.2019.0137

DO - 10.4093/dmj.2019.0137

M3 - Article

C2 - 31441247

AN - SCOPUS:85072118225

SN - 2233-6079

VL - 43

SP - 398

EP - 406

JO - Diabetes and Metabolism Journal

JF - Diabetes and Metabolism Journal

IS - 4

ER -

2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea

Abstract

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this